Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.2B | 18.5B | 18.8B | 18.0B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.7B | 2.2B | 1.6B | 2.0B |
Other operating expenses | 941M | 865M | 1.0B | 1.1B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 10.4B | 10.7B | 11.9B | 11.0B |
Tax provision | 2.2B | 2.2B | 2.5B | 2.4B |
Net income | 8.2B | 8.5B | 9.4B | 8.6B |
Basic EPS | 7.3 | 7.5 | 8.3 | 7.6 |
Diluted EPS | 7.3 | 7.5 | 8.3 | 7.6 |
Basic average shares | 1.1B | 1.1B | 1.1B | 1.1B |
Diluted average shares | 1.1B | 1.1B | 1.1B | 1.1B |
EBITDA | — | — | — | — |
Net income from continuing op. | 10.4B | 10.7B | 11.9B | 11.0B |
Minority interests | 3M | 4M | -1M | 0 |
Preferred stock dividends | — | — | — | — |